Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10

Drug and Alcohol Dependence

Volumn 158, Issue , 2016, Pages 181-185

  Moreira, Fernanda Pedrotti ^a   Medeiros, João Ricardo Carvalho ^a   Lhullier, Alfredo Cardoso ^a   Souza, Luciano Dias de Mattos ^a   Jansen, Karen ^a,d   Portela, Luis Valmor ^b   Lara, Diogo R ^c   Silva, Ricardo Azevedo da ^a   Wiener, Carolina David ^a   Oses, Jean Pierre ^a,d  

^a CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Biochemical marker; Cocaine; Cytokines; IL 10; IL 6

Indexed keywords

BIOLOGICAL MARKER; COCAINE; INTERLEUKIN 10; INTERLEUKIN 6; CYTOKINE; IL10 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INNATE IMMUNITY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TH1 TH2 BALANCE; ADOLESCENT; BLOOD; BRAZIL; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; BRAZIL; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; YOUNG ADULT;

EID: 84951774520     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.11.024     Document Type: Article

References (35)

1. Araos P., Pedraz M., Serrano A., Lucena M., Barrios V., Garcia-Marchena N., Campos-Cloute R., Ruiz J.J., Romero P., Suarez J., Baixeras E., de la Torre R., Montesinos J., Guerri C., Rodriguez-Arias M., Minarro J., Martinez-Riera R., Torrens M., Chowen J.A., Argente J., Mason B.J., Pavon F.J., Rodriguez de Fonseca F. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol. 2014.
2. Barros A., Victora C. A nationwide wealth score based on the 2000 Brazilian demographic census. Rev. Saúde Pública 2005, 39:523-529.
3. Benito C., Tolon R.M., Pazos M.R., Nunez E., Castillo A.I., Romero J. Cannabinoid CB2 receptors in human brain inflammation. Br. J. Pharmacol. 2008, 153(2):277-285.
4. Bromander S., Anckarsater R., Kristiansson M., Blennow K., Zetterberg H., Anckarsater H., Wass C.E. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J. Neuroinflamm. 2012, 9:242.
5. Buchsbaum D.G., Buchanan R.G., Welsh J., Centor R.M., Schnoll S.H. Screening for drinking disorders in the elderly using the CAGE questionnaire. J. Am. Geriatr. Soc. 1992, 40(7):662-665.
6. Chahua M., Sanchez-Niubo A., Torrens M., Sordo L., Bravo M.J., Brugal M.T., Domingo-Salvany A. Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders. Qual. Life Res. 2015.
7. Chen B.T., Bowers M.S., Martin M., Hopf F.W., Guillory A.M., Carelli R.M., Chou J.K., Bonci A. Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 2008, 59(2):288-297.
8. Ersche K.D., Hagan C.C., Smith D.G., Abbott S., Jones P.S., Apergis-Schoute A.M., Doffinger R. Aberrant disgust responses and immune reactivity in cocaine-dependent men. Biol. Psychiatry 2014, 75(2):140-147.
9. Fox H.C., D'Sa C., Kimmerling A., Siedlarz K.M., Tuit K.L., Stowe R., Sinha R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum. Psychopharmacol. 2012, 27(2):156-166.
10. Gan X., Zhang L., Newton T., Chang S.L., Ling W., Kermani V., Berger O., Graves M.C., Fiala M. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. Clin. Immunol. Immunopathol. 1998, 89(2):181-190.
11. Ghosh A., Birngruber T., Sattler W., Kroath T., Ratzer M., Sinner F., Pieber T.R. Assessment of blood-brain barrier function and the neuroinflammatory response in the rat brain by using cerebral open flow microperfusion (cOFM). PLOS ONE 2014, 9(5):e98143.
12. Goldstein R.Z., Alia-Klein N., Tomasi D., Zhang L., Cottone L.A., Maloney T., Telang F., Caparelli E.C., Chang L., Ernst T., Samaras D., Squires N.K., Volkow N.D. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?. Am. J. Psychiatry 2007, 164(1):43-51.
13. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10(11):1387-1394.
14. Hermida-Ameijeiras A., Mendez-Alvarez E., Sanchez-Iglesias S., Sanmartin-Suarez C., Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem. Int. 2004, 45(1):103-116.
15. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162(8):1403-1413.
16. Little K.Y., Ramssen E., Welchko R., Volberg V., Roland C.J., Cassin B. Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Res. 2009, 168(3):173-180.
17. Louveau A., Smirnov I., Keyes T.J., Eccles J.D., Rouhani S.J., Peske J.D., Derecki N.C., Castle D., Mandell J.W., Lee K.S., Harris T.H., Kipnis J. Structural and functional features of central nervous system lymphatic vessels. Nature 2015, 523(7560):337-341.
18. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol. Lett. 2008, 29(3):287-291.
19. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24(1):27-53.
20. Mao J.T., Huang M., Wang J., Sharma S., Tashkin D.P., Dubinett S.M. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol. 1996, 172(2):217-223.
21. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013, 30(4):297-306.
22. Narvaez J.C., Magalhaes P.V., Fries G.R., Colpo G.D., Czepielewski L.S., Vianna P., Chies J.A., Rosa A.R., Von Diemen L., Vieta E., Pechansky F., Kapczinski F. Peripheral toxicity in crack cocaine use disorders. Neurosci. Lett. 2013, 544:80-84.
23. Piechota M., Korostynski M., Solecki W., Gieryk A., Slezak M., Bilecki W., Ziolkowska B., Kostrzewa E., Cymerman I., Swiech L., Jaworski J., Przewlocki R. The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol. 2010, 11(5):R48.
24. Porrino L.J., Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb. Cortex 2000, 10(3):326-333.
25. Porter J.N., Olsen A.S., Gurnsey K., Dugan B.P., Jedema H.P., Bradberry C.W. Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J. Neurosci. 2011, 31(13):4926-4934.
26. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26(8):761-788.
27. Rosenblat J.D., Brietzke E., Mansur R.B., Maruschak N.A., Lee Y., McIntyre R.S. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J. Affect. Disord. 2015, 188:149-159.
28. Rosenblat J.D., Cha D.S., Mansur R.B., McIntyre R.S. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 53:23-34.
29. Smythies J., Galzigna L. The oxidative metabolism of catecholamines in the brain: a review. Biochim. Biophys. Acta 1998, 1380(2):159-162.
30. Sousa A., Raposo F., Fonseca S., Valente L., Duarte F., Goncalves M., Tuna D., Paiva J.A. Measurement of cytokines and adhesion molecules in the first 72hours after severe trauma: association with severity and outcome. Dis. Markers 2015, 2015:747036.
31. Streit W.J. Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front. Aging Neurosci. 2010, 2:22.
32. Taniguchi T., Koido Y., Aiboshi J., Yamashita T., Suzaki S., Kurokawa A. The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am. J. Emerg. Med. 1999, 17(6):548-551.
33. UNODC United Nations Office on Drugs and Crime. World Drug Report 2014, UNODC, New York.
34. Wisor J.P., Schmidt M.A., Clegern W.C. Cerebral microglia mediate sleep/wake and neuroinflammatory effects of methamphetamine. Brain Behav. Immun. 2011, 25(4):767-776.
35. Yamamoto B.K., Moszczynska A., Gudelsky G.A. Amphetamine toxicities: classical and emerging mechanisms. Ann. N. Y. Acad. Sci. 2010, 1187:101-121.